Nebius Group N.V.
NBISNebius Group N.V.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
Biggest watch item: the price is already 28 weeks into its uptrend — timing risk, not thesis risk.
The price is in a confirmed uptrend (28 weeks in). Underneath, the last four quarters read improving — profit −138.0% year on year. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Nebius Group N.V. trades at $209, in a confirmed uptrend and 28 weeks into that stage. That is +31.3% against its own 200-day average. It sits at 62% of a 52-week range of $83 to $287. On relative strength it is currently behind the S&P 500 on a trailing-13-week view (5 weeks and counting).
Today the stock is in a confirmed uptrend — week 28 of stage 2. At $209 it trades +31.3% versus its 200-day average and sits at 62% of its 52-week range ($83–$287).
Against the market, two honest reads. Cumulative: over the last 1.9 years the stock moved +970% while the S&P 500 moved +30% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (5 weeks and counting; last ahead the week of 2026-08-14) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
Nebius Group N.V. trades at 1,274.6× P/E, against too little history to rank. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 1,274.6× is against too little history to rank. This is a comparison against the stock's own history — not a claim about what it is worth.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Turning around Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Nebius Group N.V. reads as turning around on its fundamental arc. Turning around — profit growth swung from −233.3% at the trough to +20.0%, a 2-quarter improving streak, ROE lifting at 0.2%. The read is built from 12 quarters across 4 curves, on partial evidence.
Why it matters: growth inflections are where re-ratings start — the curves say a turn is forming, so the question becomes whether the next quarters confirm it.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +488.9% | +275.6% | — | — |
| EPS | — | −40.8% | — | — |
| Stock price | +110.8% | — | — | — |
4-Factor Sector Score
55.9/100 — rank 7 of 24 in Internet Content & Information · 75% evidence confidence
Nebius Group N.V. scores 55.9 out of 100 against the 24 companies it is compared with in Internet Content & Information, ranking 7. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 27.1 + 6.3 + 8.5 + 14 = 55.9. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Nebius Group N.V. reported $0.6 B of revenue in the Jun 26 quarter, +427.3% year on year. That is the 6th straight quarter of year-on-year growth. Over 4 years it has compounded at −42.2% a year. The last full year, FY25, came in at $0.5 B. The last four reported quarters add to $1.4 B.
FY25 revenue came in at $0.5 B (+488.9% on the year), capping 4 years at −42.2% compound. The latest quarter (Jun 26) printed $0.6 B, +427.3% year on year — the 6th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +500.6% growth against the decade's −42.2% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +491.3% over the last 4 quarters against −47.4%/yr over the last 8 — accelerating; TTM profit +20.0% vs +22.5%/yr — stabilising.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Nebius Group N.V.'s operating margin is −31.0% in the Jun 26 quarter, +69.0 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −2,900.0% to −3.8%. The current quarter sits inside that band.
The latest quarter's operating margin is −31.0%, +69.0 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −2,900.0%–−3.8%.
Why the margin moved: operating margin went +69.0 pp year on year while gross margin went +14.0 pp — the gain came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Nebius Group N.V. posted a net loss of $0.2 B in the Jun 26 quarter. Full-year FY25 profit was $0.0 B. That loss is 32.8% of the quarter's revenue. The same quarter a year earlier earned $0.5 B. 8 of the last 12 reported quarters were loss-making.
Jun 26 profit was $−0.2 B, −138.0% year on year. On the full year, FY25 printed $0.0 B (null).
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Nebius Group N.V.'s cash-flow history is too thin to judge how much reported profit converts into cash. In FY25 that was $0.4 B of operating cash against $0.0 B of profit. After $4.1 B of capital spending, $−3.7 B was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.
FY25: operating cash of $0.4 B against reported profit of $0.0 B, leaving free cash of $−3.7 B after $4.1 B of capital spending.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Nebius Group N.V. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $5.0 B over the last 3 years. Averaged over those years that is 314.5% of FY25 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $5.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
Nebius Group N.V. earns a ROE of 0% in FY25. That is up from a trough of −11% in FY24. Return on invested capital clears the cost of that capital by −14.7 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 1.9% net margin on 0.04× asset turns.
FY25 ROE is 0%, recovered from a FY24 trough of −11% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY25): 1.9% net margin × 0.04× asset turns × 2.71× balance-sheet leverage ≈ 0.2% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: −4.1% − 10.6% = a −14.7 pp spread. The 10.6% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Dividend
Nebius Group N.V. pays no dividend. Across the last 12 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.
Nebius Group N.V. does not currently pay a dividend. Across the last 12 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Nebius Group N.V. carries total debt of $10.1 B against shareholder equity of $10.3 B as of Jun 26, a debt-to-equity of 0.97. On the annual view that ratio went from 0.47 in FY21 to 1.07 in FY25. Read the returns elsewhere on this page with that leverage in mind.
Jun 26: total debt of $10.1 B against shareholder equity of $10.3 B — a debt-to-equity of 0.97. On the annual view, debt-to-equity went from 0.47 (FY21) to 1.07 (FY25). Read the returns on this page with that leverage in mind.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
19.8% of Nebius Group N.V.'s tradable float is currently sold short — a large bloc is positioned against it. At typical trading volumes those positions would take about 1.9 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 19.8% of the float is sold short, and at typical trading volumes it would take about 1.9 days to buy those positions back. A large bloc is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Nebius Group N.V.: the Z-score reads 1.49. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits inside the distress zone. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
🚨 Why it matters: a Z-score of 1.49 is inside the distress zone — the balance sheet is a real risk, not a detail.
The safety line in one sentence: the Z-score reads 1.49.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Match Group, Inc.MTCH | 69.5/100Favorable setup81% evidence | BREAKING OUT | 21.7/35 Revenue 2% · PAT 21.6% · OPM change 6.6 pp 83% evidence | 15.5/25 ROCE 6.9% · OPM 27.4% 76% evidence | 13.9/20 P/E 11.7× · PEG 0.4 65% evidence | 18.4/20 RS sector 28.4% · RS bench 17.7% · 1Y 13.2%8 of 12 weeks ahead 100% evidence |
| Exact sum: 21.7 + 15.5 + 13.9 + 18.4 = 69.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2EverQuote, Inc.EVER | 69.1/100Favorable setup71% evidence | BREAKING OUT | 28.2/35 Revenue 24.5% · PAT 100% · OPM change 7.5 pp 83% evidence | 14.2/25 ROCE 11.9% · OPM 12.3% 76% evidence | 11.5/20 P/E 5.2× · PEG — 15% evidence | 15.2/20 RS sector 12% · RS bench 1.3% · 1Y -8.5%12 of 12 weeks ahead 100% evidence |
| Exact sum: 28.2 + 14.2 + 11.5 + 15.2 = 69.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Opera LimitedOPRA | 65.0/100Favorable setup81% evidence | ASLEEP | 23.9/35 Revenue 23.7% · PAT 38.1% · OPM change 2.1 pp 83% evidence | 13.3/25 ROCE 3.1% · OPM 16.9% 76% evidence | 14.7/20 P/E 11.3× · PEG 0.33 65% evidence | 13.1/20 RS sector 15.6% · RS bench 6.2% · 1Y -2.1%5 of 12 weeks ahead 100% evidence |
| Exact sum: 23.9 + 13.3 + 14.7 + 13.1 = 65 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Alphabet Inc.GOOGL | 64.6/100Mixed-positive evidence85% evidence | ASLEEP | 21.4/35 Revenue 20.1% · PAT 100% · OPM change 1.6 pp 95% evidence | 20.5/25 ROCE 18.5% · OPM 34% 76% evidence | 12.8/20 P/E 17.8× · PEG 0.47 65% evidence | 9.9/20 RS sector 8% · RS bench -0.6% · 1Y 34.6%1 of 12 weeks ahead 100% evidence |
| Exact sum: 21.4 + 20.5 + 12.8 + 9.9 = 64.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Spotify Technology S.A.SPOT | 60.4/100Mixed-positive evidence77% evidence | TURNING | 21.6/35 Revenue 9% · PAT 100% · OPM change 4 pp 71% evidence | 13.6/25 ROCE 8.2% · OPM 13.7% 76% evidence | 11.1/20 P/E 29.2× · PEG 0.91 65% evidence | 14.1/20 RS sector 5.8% · RS bench -4.4% · 1Y -25.5%6 of 12 weeks ahead 100% evidence |
| Exact sum: 21.6 + 13.6 + 11.1 + 14.1 = 60.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Reddit, Inc.RDDT | 58.3/100Mixed-positive evidence75% evidence | ASLEEP | 30.6/35 Revenue 66.6% · PAT 100% · OPM change 15.2 pp 95% evidence | 14.1/25 ROCE 8.1% · OPM 28.8% 76% evidence | 9.2/20 P/E 40.4× · PEG — 15% evidence | 4.4/20 RS sector -8.1% · RS bench -17.5% · 1Y -40.4%6 of 12 weeks ahead 100% evidence |
| Exact sum: 30.6 + 14.1 + 9.2 + 4.4 = 58.3 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -8.1% and the one-year return is -40.4%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 7Nebius Group N.V.this pageNBIS | 55.9/100Mixed-positive evidence75% evidence | ASLEEP | 27.1/35 Revenue 100% · PAT 29.8% · OPM change 75.6 pp 95% evidence | 6.3/25 ROCE -1.2% · OPM -30.2% 76% evidence | 8.5/20 P/E 1212.2× · PEG — 15% evidence | 14.0/20 RS sector 42% · RS bench 32.6% · 1Y 110.8%6 of 12 weeks ahead 100% evidence |
| Exact sum: 27.1 + 6.3 + 8.5 + 14 = 55.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Taboola.com Ltd.TBLA | 55.1/100Thin evidence · provisional58% evidence | ASLEEP | 23.6/35 Revenue 9.6% · PAT 100% · OPM change 16.4 pp 62% evidence | 12.3/25 ROCE 6% · OPM 14.9% 76% evidence | 11.1/20 P/E 8.2× · PEG — 15% evidence | 8.1/20 RS sector -2.7% · RS bench -10.9% · 1Y 8.9%5 of 12 weeks ahead 70% evidence |
| Exact sum: 23.6 + 12.3 + 11.1 + 8.1 = 55.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 9Meta Platforms, Inc.META | 54.6/100Mixed-positive evidence85% evidence | TURNING | 12.4/35 Revenue 27.6% · PAT -4.8% · OPM change -8.2 pp 95% evidence | 21.9/25 ROCE 22.7% · OPM 34.8% 76% evidence | 5.1/20 P/E 21× · PEG 2.81 65% evidence | 15.2/20 RS sector 9.3% · RS bench -0.6% · 1Y -13.5%2 of 12 weeks ahead 100% evidence |
| Exact sum: 12.4 + 21.9 + 5.1 + 15.2 = 54.6 · Decision use: Price leads the evidence: RS versus the benchmark is -0.6%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 10JOYY Inc.JOYY | 51.9/100Mixed-positive evidence81% evidence | LEADER | 10.5/35 Revenue 0.9% · PAT -86.8% · OPM change -1.2 pp 83% evidence | 10.0/25 ROCE 0.1% · OPM 1.1% 76% evidence | 14.7/20 P/E 13.5× · PEG 0.3 65% evidence | 16.7/20 RS sector 25.1% · RS bench 14.6% · 1Y 25.8%11 of 12 weeks ahead 100% evidence |
| Exact sum: 10.5 + 10 + 14.7 + 16.7 = 51.9 · Decision use: Price leads the evidence: RS versus the benchmark is 14.6%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 11Nextdoor Holdings, Inc.NXDR | 51.1/100Thin evidence · provisional55% evidence | BREAKING OUT | 20.2/35 Revenue 6.8% · PAT — · OPM change 25 pp 62% evidence | 4.3/25 ROCE -3.4% · OPM -24.9% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 16.6/20 RS sector 29.2% · RS bench 17.8% · 1Y 7.4%11 of 12 weeks ahead 70% evidence |
| Exact sum: 20.2 + 4.3 + 10 + 16.6 = 51.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 12Snap Inc.SNAP | 48.0/100Mixed-negative evidence61% evidence | TURNING | 21.2/35 Revenue 10.3% · PAT — · OPM change 9.3 pp 62% evidence | 6.3/25 ROCE -1.2% · OPM -4.9% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 10.5/20 RS sector -3.3% · RS bench -13.5% · 1Y -29.9%1 of 12 weeks ahead 100% evidence |
| Exact sum: 21.2 + 6.3 + 10 + 10.5 = 48 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Weibo CorporationWB | 46.0/100Mixed-negative evidence81% evidence | BASING | 13.3/35 Revenue 1.4% · PAT 5.7% · OPM change -1.5 pp 83% evidence | 13.7/25 ROCE 1.9% · OPM 26.3% 76% evidence | 16.3/20 P/E 6.1× · PEG 0.13 65% evidence | 2.7/20 RS sector -26.6% · RS bench -33.9% · 1Y -48.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 13.3 + 13.7 + 16.3 + 2.7 = 46 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 14Zillow Group, Inc.ZG | 43.3/100Mixed-negative evidence64% evidence | BASING | 20.9/35 Revenue 16.8% · PAT — · OPM change 6.6 pp 62% evidence | 8.9/25 ROCE 0.8% · OPM 5.1% 76% evidence | 8.7/20 P/E 165.6× · PEG — 15% evidence | 4.8/20 RS sector -33.2% · RS bench -40.8% · 1Y -61.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 20.9 + 8.9 + 8.7 + 4.8 = 43.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Groupon, Inc.GRPN | 41.3/100Thin evidence · provisional58% evidence | TURNING | 11.0/35 Revenue 2.7% · PAT — · OPM change -4.4 pp 62% evidence | 6.3/25 ROCE -1.4% · OPM -2.8% 76% evidence | 9.9/20 P/E 19.2× · PEG — 15% evidence | 14.1/20 RS sector 12.1% · RS bench 1.7% · 1Y -14.2%10 of 12 weeks ahead 70% evidence |
| Exact sum: 11 + 6.3 + 9.9 + 14.1 = 41.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16RUM Group Inc.RUM | 41.2/100Thin evidence · provisional58% evidence | TURNING | 13.0/35 Revenue 1% · PAT — · OPM change -0.1 pp 62% evidence | 3.4/25 ROCE -12.6% · OPM -153.6% 76% evidence | 9.0/20 P/E 47.1× · PEG — 15% evidence | 15.8/20 RS sector 28% · RS bench 16.8% · 1Y 7.9%5 of 12 weeks ahead 70% evidence |
| Exact sum: 13 + 3.4 + 9 + 15.8 = 41.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17WEBTOON Entertainment Inc.WBTN | 40.6/100Thin evidence · provisional55% evidence | BASING | 17.7/35 Revenue 2.2% · PAT — · OPM change 5.7 pp 62% evidence | 7.1/25 ROCE -0.6% · OPM -2.5% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 5.8/20 RS sector -11.7% · RS bench -20.8% · 1Y -51.1%1 of 12 weeks ahead 70% evidence |
| Exact sum: 17.7 + 7.1 + 10 + 5.8 = 40.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 18Yelp Inc.YELP | 38.4/100Mixed-negative evidence75% evidence | ASLEEP | 12.8/35 Revenue 2% · PAT -2.1% · OPM change -0.6 pp 83% evidence | 12.6/25 ROCE 3.3% · OPM 7.6% 76% evidence | 8.3/20 P/E 11.3× · PEG 2.14 65% evidence | 4.7/20 RS sector -19% · RS bench -26.8% · 1Y -34.8%1 of 12 weeks ahead 70% evidence |
| Exact sum: 12.8 + 12.6 + 8.3 + 4.7 = 38.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Upwork Inc.UPWK | 37.2/100Mixed-negative evidence65% evidence | TURNING | 10.4/35 Revenue 2.5% · PAT -53.6% · OPM change -3.4 pp 83% evidence | 13.0/25 ROCE 4.2% · OPM 16.7% 76% evidence | 10.4/20 P/E 13.5× · PEG — 15% evidence | 3.4/20 RS sector -33.3% · RS bench -40.8% · 1Y -57.4%1 of 12 weeks ahead 70% evidence |
| Exact sum: 10.4 + 13 + 10.4 + 3.4 = 37.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20StubHub Holdings, Inc.STUB | 34.4/100Thin evidence · provisional55% evidence | ASLEEP | 12.8/35 Revenue -0.8% · PAT — · OPM change -0.9 pp 62% evidence | 8.6/25 ROCE 0.6% · OPM 5.8% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.0/20 RS sector -43.9% · RS bench -50.4% · 1Y -68.1%6 of 12 weeks ahead 70% evidence |
| Exact sum: 12.8 + 8.6 + 10 + 3 = 34.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 21Genius Sports LimitedGENI | 33.9/100Thin evidence · provisional55% evidence | TURNING | 13.4/35 Revenue 33.3% · PAT — · OPM change -8.8 pp 62% evidence | 4.3/25 ROCE -5.8% · OPM -23% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 6.2/20 RS sector -9.5% · RS bench -20% · 1Y -48.2%11 of 12 weeks ahead 70% evidence |
| Exact sum: 13.4 + 4.3 + 10 + 6.2 = 33.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 22Pinterest, Inc.PINS | 33.5/100Adverse evidence71% evidence | ASLEEP | 11.6/35 Revenue 16.3% · PAT -82.4% · OPM change -3.9 pp 83% evidence | 6.8/25 ROCE -1.8% · OPM -8% 76% evidence | 9.4/20 P/E 38.2× · PEG — 15% evidence | 5.7/20 RS sector -16.2% · RS bench -24.9% · 1Y -47.9%9 of 12 weeks ahead 100% evidence |
| Exact sum: 11.6 + 6.8 + 9.4 + 5.7 = 33.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23People IncorporatedPPLI | 31.0/100Adverse evidence64% evidence | ASLEEP | 9.2/35 Revenue -9.4% · PAT — · OPM change -14.5 pp 62% evidence | 6.8/25 ROCE -0.6% · OPM -9.5% 76% evidence | 8.9/20 P/E 108.2× · PEG — 15% evidence | 6.1/20 RS sector -2.5% · RS bench -10.4% · 1Y 3.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 9.2 + 6.8 + 8.9 + 6.1 = 31 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24Trump Media & Technology Group Corp.DJT | 29.1/100Thin evidence · provisional57% evidence | ASLEEP | 7.2/35 Revenue 0% · PAT — · OPM change -28873.5 pp 62% evidence | 5.2/25 ROCE -27.2% · OPM — 61% evidence | 10.0/20 P/E — · PEG — 0% evidence | 6.7/20 RS sector -18.7% · RS bench -27.4% · 1Y -51%3 of 12 weeks ahead 100% evidence |
| Exact sum: 7.2 + 5.2 + 10 + 6.7 = 29.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Nebius Group N.V.'s stock price today?
Nebius Group N.V. trades at $209, +110.8% over the past year. The company is valued at $57.0 B. The stock sits at 62% of its 52-week range of $83–$287, +31.3% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 28 weeks in. — as of 17 September 2026.
What were Nebius Group N.V.'s latest quarterly results?
Nebius Group N.V. reported revenue of $0.6 B and a net loss of $0.2 B for the Jun 26 quarter. Revenue rose 427.3% and profit fell 138.0% year on year. Earnings per share were $−0.68. The operating margin was −31.0%, 69.0 pp higher than a year earlier. — as of 17 September 2026.
What is Nebius Group N.V.'s revenue?
Nebius Group N.V. reported revenue of $0.6 B in the Jun 26 quarter, +427.3% year on year. For the full FY25 fiscal year, revenue was $0.5 B (+488.9%). Over the last 4 years revenue compounded at −42.2% a year. — as of 17 September 2026.
What is Nebius Group N.V.'s profit?
Nebius Group N.V. earned $−0.2 B of net profit in the Jun 26 quarter, −138.0% year on year. Full-year FY25 profit was $0.0 B. The operating margin ran −31.0% in the latest quarter. — as of 17 September 2026.
What is Nebius Group N.V.'s market cap?
Nebius Group N.V.'s market capitalisation is $57.0 B at a stock price of $209. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 17 September 2026.
Does Nebius Group N.V. pay a dividend?
No — Nebius Group N.V. has declared no dividend per share in any of its last 12 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 17 September 2026.
Is Nebius Group N.V. growing?
Yes — Nebius Group N.V. is growing: latest-quarter revenue +427.3% year on year, profit −138.0%, and the margin +69.0 pp at −31.0%. The earnings engine currently reads: improving — as of 17 September 2026.
How is Nebius Group N.V. performing?
Nebius Group N.V. is in a confirmed uptrend, 28 weeks in. Its latest quarter's revenue rose 427.3% and profit fell 138.0% year on year. Against the S&P 500 it has been behind on a trailing-13-week view for 5 weeks. This describes what the data did, not a rating. — as of 17 September 2026.
What stage is Nebius Group N.V. in?
Turning around — profit growth swung from −233.3% at the trough to +20.0%, a 2-quarter improving streak, ROE lifting at 0.2%. The read comes from the last 12 quarters of growth (revenue growth +491.3% latest, profit growth +20.0% latest, eps growth −108.0% latest) plus the ROE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 17 September 2026.
Is Nebius Group N.V. in an uptrend?
Yes — the price is in a confirmed uptrend (week 28 of stage 2), trading +31.3% versus its 200-day average and at 62% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 17 September 2026.
Is Nebius Group N.V. beating the market?
Not lately — on a trailing-13-week view Nebius Group N.V. is currently behind the S&P 500 (5 weeks and counting; last ahead the week of 2026-08-14), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 1.9 years the stock moved +970% against the S&P 500's +30% — ahead of the index over the full window. — as of 17 September 2026.
Will Nebius Group N.V.'s stock price go up?
This page publishes no price forecast for Nebius Group N.V. What it measures instead: the stock price is $209, the price is in a confirmed uptrend 28 weeks in. Direction is not something this site claims to know. — as of 17 September 2026.
Is the market betting against Nebius Group N.V.?
Yes — short interest is 19.8% of Nebius Group N.V.'s tradable float, about 1.9 days to cover at typical volumes. A crowded short: a large bloc is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 17 September 2026.
Does Nebius Group N.V. have too much debt?
It is moderate — Nebius Group N.V.'s debt-to-equity is 0.99. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 17 September 2026.
What is Nebius Group N.V.'s capex?
Nebius Group N.V. spent $5.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $4.1 B. — as of 17 September 2026.
What is Nebius Group N.V.'s cash flow?
Nebius Group N.V. generated $0.4 B of operating cash flow in FY25 and $−3.7 B of free cash flow after $4.1 B of capital spending. Reported profit that year was $0.0 B, so operating cash ran ahead of profit. — as of 17 September 2026.
How financially safe is Nebius Group N.V.?
On the balance sheet, the Z-score reads 1.49 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is inside the danger band — a real balance-sheet risk. — as of 17 September 2026.
Where is Nebius Group N.V. in its business cycle?
Nebius Group N.V.'s FY25 operating margin was −115.1%, against a 5-year band of −2,900.0%–−3.8%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran −31.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 17 September 2026.
What could break the Nebius Group N.V. story?
Biggest watch item: the price is already 28 weeks into its uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 17 September 2026.
Is Nebius Group N.V. a stock worth studying right now?
This is not investment advice. The machine read: Nebius Group N.V.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 17 September 2026.
Not SEBI Registered !! Not Investment advice !!